Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT05688644

Sacral Neuromodulation in Neurogenic Patients

Conditions: Neurogenic Bladder, Neurogenic Bowel, Urge Incontinence, Overactive Bladder, Retention, Urinary, Fecal Incontinence

Sex: All
Ages: 18 Years – N/A
Enrollment: 100
Sponsor: Omri Schwarztuch Gildor

Location: Israel

Summary

The goal of this observational study is to evaluate efficacy and safety of sacral neuromodulation in neurogenic patients compared to non-neurogenic (idiopathic) patients. [. The main question[s] it aims to answer are:determine efficacy and safety of the therapy in neurogenic patients.compare outcomes of the therapy to idiopathic patients.If there is a comparison group: Researchers will compare the outcomes of the therapy between the neurogenic and non-neurogenic subset of patients.

Eligibility Criteria

Inclusion Criteria:Patients who underwent InterStim II advanced evaluation for approved indicationExclusion Criteria:N/A

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05688644). StuddyBuddy aggregates publicly available trial information.